INTRODUCTION
It has been both well-established and well-documented that cardiac catherization (CC) is the gold standard to determine stenosis in symptomatic patients with typical angina. 1 However, it is an invasive test that increases health expenditures and complications, in contrast to less invasive testing. 2 Less invasive testing for typical angina exists in the form of stress EKG, single photon emission computerized tomography myocardial perfusion imaging (SPECT MPI), and cardiac computerized tomography angiography (CCTA). CCTA is an advance in cardiac imaging, capable of noninvasively characterizing patency and compromise of the coronary arteries. SPECT MPI is another well-established method to determine levels of functional ischemia and physiologic perfusion defects. If determined to be effective, these less invasive, less expensive imaging modalities would be preferable to CC as first line diagnostic maneuvers, with CC remaining the gold standard for final diagnosis, and therapy, if necessary. We sought to demonstrate the interrelationship between these three studies (CC, CCTA, MPI) and their ability to determine the appropriate treatment (medical therapy 3 vs. revascularization), by clarifying clear indications for their sequential use. We set out to devise a streamlined approach and algorithm for cardiac imaging and risk assessment in symptomatic patients with stable angina and an abnormal EKG. Additionally, we sought to further demonstrate how CCTA, MPI, and CC correlate or differ, and relate their results to the course of treatment. Using this information, we have devised a novel imaging algorithm that can be used clinically to optimize effectiveness of these imaging modalities, while simultaneously reducing those that are unnecessary and invasive.
MATERIALS AND METHODS

Study Population
We retrospectively screened the database of patients to identify those who received MPI, CCTA, and CC from February 2009-June 2014 within a 30 month period. The study population includes patients who underwent all three imaging studies within the aforementioned time period, with the MPI exam less than 30 months before CC. In total, 56 patients were identified who met the initial criteria. 12 patients were excluded due to the MPI taking place after CC intervention, 3 were excluded due to the MPI taking place >30 months before CC, and 2 were excluded due to a congenital anomaly being the reason for imaging. 3 patients who had MPI after CC were included in the study since no intervention was performed. All patients who underwent revascularization were subsequently medically managed according to national guidelines. 3 Approval from the Institutional Review Board at both institutions was obtained prior to initiation of the study. Table 1 further describes patient demographics.
MPI Imaging and Analysis
SPECT MPI studies were performed based on American Society of Nuclear Cardiology guidelines. 4 Exercise stress was obtained by
Taylor Graber et al.: Imaging for Chest Pain Assessment treadmill exercise using the standard Bruce protocol. 5 SPECT images were acquired using dual-head gamma cameras (Vertex EPIC, ADAC Laboratories, Milpitas, CA, USA). Short-and long-axis images were reconstructed using a Butterworth filter. Image interpretation was performed by two experienced nuclear cardiologists based on semiquantitative polar maps of perfusion, using a 17-segment model. 6, 7 The following results were obtained from each MPI study: normal/ abnormal result, gated wall motion, area of myocardium affected by ischemia, left ventricular ejection fraction, summed stress score (SSS), summed rest score (SRS), summed difference score (SDS), and transient ischemic dilation (TID). The SRS and the SSS were calculated by adding the segmental perfusion scores during rest and stress, respectively, and the SDS was calculated by subtracting the SRS from the SSS. Two different board certified nuclear cardiologists (who were blinded to the results of the CCTA and CC studies) graded the severity of ischemia classified by SSS: normal (0-3),mildly abnormal (>3.0-8.0), moderately to severely abnormal (>8.0), 8 and by SDS: no ischemia (0-<2.0), mild ischemia (>2.0-4.0), moderate to severe ischemia (>4.0). 9 If a patient had a SSS< 8.0 or SDS< 4.0 but a TID >1.25, then a grade of severe ischemia was given. [10] [11] [12] [13] The final statistic was an average of the individual grades.
CCTA Imaging and Analysis
All CCTAs were obtained using 64-slice CT scanners (Somatom Definition; Siemens Medical Solutions, Forchheim, Germany; and Brilliance 64; Philips, Best, the Netherlands). Before CCTA, all patients with an average heart rate of 65 beats per minute or greater received oral metoprolol 50-100 mg in the absence of contraindications, and were administered sublingual nitroglycerin 0.2-0.6 mg immediately before scanning. During image acquisition, 60-80 mL of contrast were injected, followed by a saline flush. Helical scan data were obtained using the retrospective ECG-gating protocol. Image acquisition included the coronary arteries, left ventricle, and proximal ascending aorta. All CCTA results were transferred to an external three-dimensional workstation, and were analyzed independently by two experienced CCTA radiologists who were blinded to the results of the MPI and CC. The radiologists graded the severity of luminal stenosis of the coronary artery, classified as mild (0-49%), moderate (50-69%), or severe (≥70%). 14 The final statistic was determined as an average of these scores.
CC Imaging and Analysis
Coronary interventions were performed using the Judkins Technique with 5-or 6-F (femoral artery access) or 4-or 5-F (radial artery access) guiding catheters according to current standard methods. Anticoagulants administered were heparin, Angiomax, or Glycoprotein IIb/IIIa inhibitors, per the cardiologist's discretion. An intravenous (IV) bolus of heparin at 70 units/kg was given with frequent activated clotting times (ACT) to adjust heparin by further IV bolus dosing to maintain ACT between 250-300 seconds. 15 An IV bolus of Angiomax at 0.75 mg/kg was given with a maintenance dose of 1.75 mg/kg/hr during the procedure, and then up to 4 hours post procedure. 16 Coronary angiograms were obtained in multiple projections. Anterograde flow of the infarct-related artery was graded according to the classification of the thrombolysis in myocardial infarction (TIMI) trial. 17 Balloon angioplasty and stenting were performed to achieve an optimal angiographic result until defined as success by ACC (American College of Cardiology). 18 All angiograms had a frame rate of 15 frames per second, and were stored digitally on a compact disc. GE cardiac catheterization camera and systems including software were utilized for imaging using standard cine films and fluoroscopy. Standard views were obtained and were operator dependent. Each CC imaging study was analyzed for the following information: ejection fraction, location of stenosis, and percentage occlusion. Two different board certified interventional cardiologists, blinded to the results of MPI and CCTA, graded each patient to a category of stenosis: mild (<50%), moderate (50-69%), and severe (≥70%). The final statistic was an average of these grades.
Statistical Analysis
Patient demographic characteristics were ascertained using means and standard deviations for continuous variables; frequencies and proportions for categorical variables. Furthermore, frequencies and proportions were ascertained for each of the assigned categorical grades for the three different tests (MPI, CCTA, CC). The Kruskal-Wallis test was used to determine the ability of each test to predict the level of therapy (medical vs. interventional). Spearman's rank correlation was used to determine the association between any pair of MPI, CCTA, and CC. Unless stated otherwise, p-values <0.05 are deemed significant. The Stata software package was used for both graphs and analysis (StataCorp 2013. Stata Statistical Software: Release 13. College Station TX: StataCorp LP).
RESULTS
39 patients were included in the current analysis. 19 patients received medical therapy, while 7 patients and 13 patients received CABG and angioplasty respectively (Table 1) . 11 patients (57.9%) and 5 patients (26.3%) within in the medical therapy treatment group presented with moderate to severe ischemia after undergoing the MPI SSS and MPI SDS imaging modalities respectively. The CCTA and CC imaging modalities rendered 16 (84.2%) patients and 9 (47.4%) patients with moderate stenosis respectively (Table 1) . Among the 7 patients within the CABG treatment group, the MPI SSS showed 4 (57.1%) patients with moderate to severe ischemia, while the MPI SDS showed 2 (28.6%) patients with moderate to severe ischemia. All 7 patients within this treatment group showed severe stenosis after undergoing the CCTA and CC imaging modalities. The MPI SSS and SDS showed that 6 (46.2%) patients presented with moderate to severe ischemia and thus received angioplasty. 11 (84.6%) patients and 13 (100%) patients within the angioplasty treatment group showed severe stenosis with the CCTA and CC imaging modalities, respectively. Of the four imaging modalities, CCTA and CC were correlated to the treatment distributions among the patients (p = <0.001 for both). Figures 1-3 showed correlations between imaging modalities by assessing the distribution of treatment modalities across specified categories. 18/18 patients (100%) with severe stenosis (>70%) on CCTA were treated with interventional therapy through either surgical intervention or angioplasty, regardless of the result from MPI. When CCTA showed mild stenosis (<50%), 3/3 (100%) patients were treated with medical therapy, and none needed interventional therapy (as defined by Hulten et al.) 19 regardless of the result from MPI. When CCTA revealed moderate stenosis (50-70%) and MPI SSS was < 8, 8/8 patients (100%) were treated with medical therapy. Conversely, with MPI SSS >8, 8/10 (80%) were treated with medical therapy and 2/10 (20%) were treated with inter ventional therapy (Figure 1) . 18/18 patients (100%) with severe stenosis from CCTA were treated with interventional therapy, and with mild stenosis 3/3 patients (100%) were treated with medical therapy. With moderate stenosis and an MPI SDS score of < 4.0, 12/12 patients (100%) were treated with medical therapy. With an SDS score of > 4.0, 4/6 patients (67%) were treated with medical therapy and 2/6 patients (33%) were treated with interventional therapy (Figure 2) . Figure 3 shows that with severe stenosis on CCTA, all 18/18 patients had severe stenosis on CC, and all underwent interventional therapy. Severe stenosis: all patients received interventional therapy Mild stenosis: all patients received medical therapy Moderate stenosis and MPI SSS <8: all patients received medical therapy.
In certain situations in our study when CCTA showed 50-70% stenosis, the additional use of MPI added clinically useful information. When SDS was <4.0, all patients received medical therapy. When SDS was >4.0, 4/6 patients underwent medical therapy, while 2/6 patients underwent interventional treatment. The 2 patients who received interventional treatment also had limiting symptoms at the time of treatment (severe chest pain on exercise stress test that also limited daily activity), while the 4 who received medical therapy did not. When combined with the results from CCTA and MPI, the presence of limiting symptoms could be used to help stratify the patients for revascularization or medical therapy. In our study, CCTA showed a strong ability to correlate to CC with severe stenosis, indicating a high true positive rate (100%). All patients who had severe stenosis from CCTA also had severe stenosis from CC and subsequently underwent interventional treatment. In this group, the additional use of CC was warranted as it helped to direct angioplasty or revascularization. It has been well-established that severe levels of coronary stenosis (>70%) as detected by CC are the gold standard to determine treatment through revascularization, either through angioplasty or bypass surgery. 20 Severe obstructions have been linked to a 40x increased relative risk for a major adverse coronary event, so with a severe stenosis result on CCTA (or multiple proximal vessel involvement), a follow up with CC and aggressive treatment would be indicated. 14, 19, 21 CC remains the gold standard to determine coronary stenosis diagnostically, but CCTA is a reliable, less invasive, and more cost effective tool. 2 Our data prompted us to develop a new imaging algorithm ( Figure 5) . A symptomatic patient with stable angina and an abnormal EKG should With mild stenosis on CCTA, 3/3 patients had mild stenosis on CC and all had medical therapy. With moderate stenosis from CCTA, 5/18 (28%) patients had mild stenosis on CC and underwent medical therapy; 9/18 (50%) patients had moderate stenosis on CC and underwent medical therapy; 4/18 patients (22%) had severe stenosis on CC with 2 receiving medical therapy and 2 interventional treatment. Figure 4 shows that using MPI by SDS as a first line diagnostic test with CCTA as a follow-up did not effectively stratify patients into categories that are predictive of treatment type. Using our algorithm ( Figure 5 ), 3/39 patients (8%) could have avoided testing with MPI and CC, 21/39 patients (54%) could have avoided MPI, and 16/39 patients (41%) could have avoided CC, with only 2/39 patients (5%) needing all three imaging studies. Thus, in our cohort, 37/39 patients (95%) could have avoided one or more tests.
DISCUSSION
Our data show that using CCTA as a first line imaging study could be used to effectively reduce non-essential imaging and can direct subsequent therapy (medical vs. interventional). CCTA showed a statistically significant correlation to the severity of stenosis on CC (p < 0.0001) and type of treatment therapy prescribed (p < 0.0001). All patients who showed mild stenosis from CCTA also had mild stenosis from CC and received medical therapy. In this group, the additional testing from either MPI or CC was not needed, as CCTA was able to effectively rule out severe disease and eliminate the need for interventional therapy. Severe stenosis: all patients underwent interventional therapy Mild stenosis: all patients received medical therapy Moderate stenosis and SDS <4: all patients received medical therapy. echocardiography), and found at a follow-up of 25 months, the primary end point (death, MI, hospitalization for unstable angina, measured procedural complication) was equivalent in both treatment arms (3.3% in CCTA group vs. 3% in functional testing group) with equivalent economic results from the each arm of the study. 24 Comparing CCTA to physiologic testing, cumulative radiation exposure (10.0 mSv vs. 11.3 mSv) and false positive results [non-invasive imaging suggesting stenosis >50% necessitating CC] (3.4% vs. 4.3%) were lower in the CCTA group than functional testing group. 24 The results of this study show noninferiority among each arm of the study, suggesting that initial cardiac imaging should be chosen that accurately predicts medical vs. interventional treatment.
LIMITATIONS OF CURRENT STUDY
First, this was a single-center study with a limited sample size. Second, the tests were not all performed at the same time (mean time between testing was 0.69 years with standard deviation of 0.91 years). To obtain sufficient patient data for analysis, this criterion for imaging was within 30 months. This could have allowed for increased luminal thrombosis, worsening of CAD, and/or clinically significant changes in this time frame. Third, it would not be ethically permissible to prospectively assign patients to all three imaging studies, and thus a retrospective analysis was utilized. Since the 39 patients were analyzed by all three studies, they were inherently difficult to stratify for medical vs. interventional treatment. Therefore, they may not be completely representative of the population with typical angina. However, even with the limited sample size, our data reinforce the literature for the correlation between the various imaging studies. Additionally, the eventual outcomes of these patients were not followed. For future study, a multi-center prospective analysis with a large patient population using this imaging and treatment algorithm would first be referred for CCTA. CCTA will then be able to determine whether severe CAD (>70% stenosis) is present. If so, the patient should be referred to CC for confirmatory diagnosis and revascularization. If severe CAD is absent, and the level of stenosis is <50%, medical treatment according to national guidelines 3 is the appropriate therapy. When the results of CCTA show moderate CAD (50-70% stenosis), additional imaging by MPI is warranted to determine the course of therapy. If the results from MPI show anything less than moderate ischemia (with a large area of ischemia, SDS >4.0, or a TID >1.25), the patient should undergo medical therapy and subsequently be monitored for progression of disease. If the results show severe ischemia, and the patient has symptoms on maximal anti-anginal medication, the patient should be referred to CC for confirmatory diagnosis and possible revascularization. This algorithm uses the benefits of each imaging modality to effectively rule in or rule out CAD. We recommend CCTA as a first line imaging modality due to its ability to rule out disease. Tamarappoo et al. 1, 22 and Budoff et al. 23 illustrated the strong negative predictive value of CCTA, indicating the ability of CCTA to determine a true negative result and rule out disease. In patients with moderate stenosis, MPI is a valuable adjunctive imaging modality that can provide additional information for symptomatic patients. In symptomatic patients with severe levels of myocardial ischemia, more aggressive treatment through revascularization can be planned. CC remains the confirmatory diagnostic study, due to its accuracy as the gold standard for coronary imaging. Using this algorithm, unnecessary testing (such as using MPI when CCTA shows severe or mild stenosis) can be avoided. Recently, data from the PROMISE trial have indicated non-inferiority of CCTA compared to functional testing. 24 The authors assigned 10,000 symptomatic patients to two treatment arms (anatomic testing with CCTA, or physiologic testing with stress EKG, MPI, stress be beneficial to assess patient outcomes. The progress of these patients should be followed over time so that adverse events can be tracked to determine if their prevention could have been predicted, and whether alterations in the imaging algorithm need to be made.
CONCLUSION
This retrospective study has helped establish the relative importance and interrelationships of CCTA, MPI, and CC. CCTA is a noninvasive imaging approach to determine CAD with high levels of sensitivity, specificity, and negative predictive value. Its use as a first line imaging modality in the patient with stable angina and an abnormal EKG is suggested by our study. Following a result from CCTA showing moderate stenosis (50-70%), MPI yields prognostic benefit to determine therapy stratification. The utilization of these imaging studies according to our algorithm should reduce the need for invasive CC, using it only for confirmatory diagnosis and eventual treatment in the setting of severe stenosis, while simultaneously avoiding the unnecessary use of MPI (such as using MPI when CCTA shows mild or severe stenosis). Future prospective analysis using our algorithm is warranted, assessing outcomes at each level of the algorithm, to measure the development of adverse coronary events and the response to the different therapies that were guided by the proposed algorithmic approach.
